Norris Medicines - News

BSE: 524414

₹14.29

₹-0.21 (-1.45%)

As on 03-Sep-2026IST

Market cap

₹14 Cr

Revenue (TTM)

₹8 Cr

P/E Ratio

--

P/B Ratio

-0.9

Div. Yield

0 %

Annual
Quarterly

Annual Reports

Annual Reports

2025

Annual Reports

2024

Annual Reports

2023

Annual Reports

2022

Annual Reports

2021

Annual Reports

2020

Annual Reports

2019

Annual Reports

2018

Annual Reports

2017

Annual Reports

2016

Annual Reports

2015

Annual Reports

2000

Annual Reports

1998

Announcements

View Announcements

Recent

Important

Board Meeting Outcome for Of Board Meeting Held On Thurday 03Rd September 2026 Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.

03-Sep-2026

Announcement under Regulation 30 (LODR)-Change in Management

14-Aug-2026

Financial Results For The Quarter Ended June 30 2026

14-Aug-2026

Board Meeting Outcome for Outcome Of Board Meeting Held On August 14 2026 Pursuant To Regulation 30 And Regulation 33 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.

14-Aug-2026

Board Meeting Intimation for Under Regulation 29 Of SEBI Listing Obligation And Disclosure Requirements 2015 For Holding Board Meeting For Approval Of Un-Audited Financial Results For The Quarter Ended June 30 2026

08-Aug-2026

Announcement under Regulation 30 (LODR)-Change in Management

30-Jul-2026

Board Meeting Outcome for Outcome Of The Board Meeting Dated 30Th July 2026.

30-Jul-2026

Certificate Under Reg. 74 (5) Of SEBI (DP) Regulations 2018

03-Jul-2026

Closure of Trading Window

24-Jun-2026

Announcement under Regulation 30 (LODR)-Change in Management

30-May-2026